Birth Control News and Research RSS Feed - Birth Control News and Research

First sexual experiences involving alcohol increase risk for young women

First sexual experiences involving alcohol increase risk for young women

If a young woman's first sexual experience involves alcohol, she is more likely to be at risk for problems such as sexual assault, and this risk may persist in her future, new research finds. [More]
Research shows more than 30,000 women die from cardiovascular disease in UK

Research shows more than 30,000 women die from cardiovascular disease in UK

More than 30,000 women die from coronary heart disease in the UK every year with over 700,000 women living with the consequences of heart disease and stroke, according to research published by The British Heart Foundation ahead of World Heart Day on 29th September. [More]
Weight loss and exercise improve ovulation in women with polycystic ovary syndrome

Weight loss and exercise improve ovulation in women with polycystic ovary syndrome

Weight loss and exercise improve ovulation in women who have polycystic ovary syndrome, a common hormone disorder that often causes infertility, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. [More]
Female mice exposed to endocrine disruptors may show decreased metabolism, physical activity in offspring

Female mice exposed to endocrine disruptors may show decreased metabolism, physical activity in offspring

Endocrine disruptors are contaminants that interfere with endocrine or hormone systems and can cause tumors, birth defects and developmental disorders in mammals. Often, these contaminants are used in a variety of consumer products, such as water bottles, dental composites and resins used to line metal food and beverage containers. [More]
Report: Birth control pills cause significant increase in stroke risk

Report: Birth control pills cause significant increase in stroke risk

Birth control pills cause a small but significant increase in the risk of the most common type of stroke, according to a comprehensive report in the journal MedLink Neurology. [More]
Free e-book provides advice for lowering breast cancer risk at every stage of life

Free e-book provides advice for lowering breast cancer risk at every stage of life

Surprisingly, preventing breast cancer can begin as early as age 2. Eating right, being physically active and keeping weight in check - even at a young age - can substantially lower breast cancer risk. [More]
New study provides biological explanation for how DMPA increases risk of HIV infection

New study provides biological explanation for how DMPA increases risk of HIV infection

In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study published in the September 1st issue of mBio, an online open-access journal of the American Society for Microbiology, provides a biological explanation for the phenomenon. [More]
Shire enters into agreement with Sanquin for CINRYZE

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE. [More]
Women's contraceptive choices often driven by relationships, sexual activity

Women's contraceptive choices often driven by relationships, sexual activity

Women's contraceptive choices are more often driven by current relationships and sexual activity than by long-term pregnancy intentions, according to Penn State College of Medicine researchers. [More]

Survey finds clear unmet need for comprehensive family planning services at health centers

As part of a unique survey of nearly 2,000 women of childbearing age who receive health care at the nation's community health centers, 90 percent reported that they were not actively seeking to become pregnant in the next 12 months. Yet more than 3 out of 10 were not using contraceptives at the time of the survey. [More]
Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. [More]
Most patients with depression excluded from antidepressant trials, study finds

Most patients with depression excluded from antidepressant trials, study finds

More than 80 percent of people with depression in the general population aren't eligible for clinical trials of antidepressant drugs, according to a study in the Journal of Psychiatric Practice. [More]
UMass Amherst scientist to study how estrogen-mimicking chemicals in the womb can increase breast cancer risk

UMass Amherst scientist to study how estrogen-mimicking chemicals in the womb can increase breast cancer risk

Much attention has been paid to genetics in breast cancer as disease rates rise, but most women have no family history of the disease, suggesting that there is an environmental risk we don't yet understand, says environmental health scientist Laura Vandenberg in the School of Public Health and Health Sciences at the University of Massachusetts Amherst. [More]
Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

More than 5,500 sociologists will convene in Chicago this August to explore ideas and scientific research relating to sexuality and many other topics, as part of the American Sociological Association's 110th Annual Meeting. This year's theme, "Sexualities in the Social World," shows the importance of research by sociologists in illuminating how social norms and social inequalities affect what sexual behavior is acceptable and who partners with whom. [More]
FDA provides safety update about Essure Birth Control Implant

FDA provides safety update about Essure Birth Control Implant

The FDA first announced their intention to provide a safety update about Essure late yesterday evening. Today's much anticipated report comes on the heals of a private citizen petition that raised serious concerns about the Essure Birth Control Implant and resulted in the launch of an FDA investigation into the birth control device. [More]
Improved birth control advice reduces unintended pregnancy rate among young women

Improved birth control advice reduces unintended pregnancy rate among young women

Providing health workers with training on how to educate young women about intrauterine devices (IUDs) and contraceptive implants reduced the rate of unintended pregnancy by almost half in a study of women seeking family planning services. [More]
Study compares costs of immediate birth control implant insertion with costs of unintended pregnancy

Study compares costs of immediate birth control implant insertion with costs of unintended pregnancy

Women who have just given birth are often motivated to prevent a rapid, repeat pregnancy. For those who prefer a contraceptive implant, getting the procedure in the hospital immediately after giving birth is more cost-effective than delaying insertion to a 6-8 week postpartum visit, according to a new study by Yale School of Medicine researchers. [More]
ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Novartis today announced new data from two Phase II studies of Zykadia (ceritinib), as well as one Phase II study of TafinlarĀ® (dabrafenib) in combination with Mekinist (trametinib) in certain patients with non-small cell lung cancer. [More]
Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures. [More]
Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly and Company announced final results of the Phase III PROCLAIM trial that will also be discussed in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. [More]
Advertisement
Advertisement